Literature DB >> 19461090

Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.

Rita Paniccia1, Emilia Antonucci, Niccolò Maggini, Eloisa Romano, Anna Maria Gori, Rossella Marcucci, Domenico Prisco, Rosanna Abbate.   

Abstract

This study sought to compare Multiplate impedance platelet aggregometry (IPA) with light transmission aggregometry (LTA) and the PFA-100 for determining the prevalence of residual platelet reactivity (RPR) by the Multiplate IPA in 297 patients with acute coronary syndrome receiving dual antiplatelet therapy. Aggregations were induced by adenosine-5 diphosphate (ADP), arachidonic acid, and collagen. PFA-100 closure times were measured by collagen and ADP and epinephrine (CEPI) cartridges. Significant correlations were observed between Multiplate IPA and LTA after all stimulations (P < .0001) and between Multiplate IPA (arachidonate and collagen) and PFA-100 CEPI closure time (P < .0001 for both). Cutoff values of Multiplate IPA (for all stimulations) were calculated for the identification of RPR. Between the Multiplate IPA and LTA good agreement was found with all 3 agonists (P < .0001 for all). Multiplate IPA might represent a reliable, handy, rapid tool to monitor antiplatelet therapy in clinical practice and for clinical investigations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461090     DOI: 10.1309/AJCPTE3K1SGAPOIZ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  18 in total

Review 1.  Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implications.

Authors:  Stavros Spiliopoulos; Georgios Pastromas
Journal:  World J Cardiol       Date:  2015-12-26

2.  Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation.

Authors:  Paolo Pieragnoli; Anna Maria Gori; Giuseppe Ricciardi; Gianmarco Carrassa; Luca Checchi; Antonio Michelucci; Raffaella Priora; Anna Paola Cellai; Rossella Marcucci; Luigi Padeletti; Rosanna Abbate
Journal:  Intern Emerg Med       Date:  2014-06-21       Impact factor: 3.397

Review 3.  Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.

Authors:  Nalyaka Sambu; Nick Curzen
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

4.  Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy.

Authors:  Monica Verdoia; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Francesco Tonon; Elvin Kedhi; Harry Suryapranata; Alessandro Carriero; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2019-10       Impact factor: 2.300

5.  Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.

Authors:  Monica Verdoia; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

6.  Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin.

Authors:  Yan Liang; Marilyn Johnston; Jack Hirsh; Guillaume Pare; Chunjian Li; Shamir Mehta; Koon K Teo; Debi Sloane; Qilong Yi; Jun Zhu; John W Eikelboom
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

7.  Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking.

Authors:  B Łabuz-Roszak; K Pierzchała; K Tyrpień
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

8.  A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy.

Authors:  Yu Ueda; Ronald H L Li; Nghi Nguyen; Eric S Ontiveros; Samantha L Kovacs; Maureen S Oldach; Karen M Vernau; Michael H Court; Joshua A Stern
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

9.  Determinants to optimize response to clopidogrel in acute coronary syndrome.

Authors:  Betti Giusti; Anna Maria Gori; Rossella Marcucci; Claudia Saracini; Anna Vestrini; Rosanna Abbate
Journal:  Pharmgenomics Pers Med       Date:  2010-04-08

10.  Attenuated platelet aggregation in patients with septic shock is independent from the activity state of myosin light chain phosphorylation or a reduction in Rho kinase-dependent inhibition of myosin light chain phosphatase.

Authors:  Benjamin Aj Reddi; Samantha M Iannella; Stephanie N O'Connor; Adam M Deane; Scott R Willoughby; David P Wilson
Journal:  Intensive Care Med Exp       Date:  2015-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.